Home Cart Sign in  
Chemical Structure| 2957-21-3 Chemical Structure| 2957-21-3

Structure of Sakuranetin
CAS No.: 2957-21-3

Chemical Structure| 2957-21-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sakuranetin is a flavonoid phytoalexin with strong antifungal activity. Sakuranetin has anti-inflammatory and antioxidant effects and can improve acute lung injury induced by LPS.

Synonyms: Sakuranetin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sakuranetin

CAS No. :2957-21-3
Formula : C16H14O5
M.W : 286.28
SMILES Code : O=C1C[C@@H](C2=CC=C(O)C=C2)OC3=C1C(O)=CC(OC)=C3
Synonyms :
Sakuranetin
MDL No. :MFCD00075651

Safety of Sakuranetin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rhizoctonia solani 100 µM 12 hours Investigate the metabolites of Sakuranetin, identified naringenin (2), sakuranetin-4′-O-β-D-xylopyranoside (3), and naringenin-7-O-β-D-xylopyranoside (4) as metabolites Molecules. 2018 Jan 29;23(2):276
Rice protoplast cells 100 µM 15 minutes pretreatment, 30 minutes co-treatment To investigate the effect of sakuranetin on endocytosis in rice protoplast cells, results showed that sakuranetin enhanced the localization of OsSYP121-GFP to the plasma membrane. Nat Commun. 2024 Apr 23;15(1):3437
HepG2 cells 100 µM 24 hours Sakuranetin significantly increased HepG2 cell activity and decreased cell death, inhibited ROS production, increased GSH content, expression of GPX4 and SLC7A11, and decreased MDA and ACSL4 expression. Drug Des Devel Ther. 2025 Jan 10;19:159-171
HepG2 cells 20 µM 24 hours To study the inductive effects of SKN on the CYP3A4 gene, it was found that SKN induces transactivation of the CYP3A4 gene via a PXR-mediated mechanism. Molecules. 2018 Jun 26;23(7):1542
Candida carpophila 0.5 µg/mL 36 hours Evaluate the direct antifungal activity of Sakuranetin on Candida carpophila, results showed Sakuranetin significantly inhibited its growth Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2305007120
Yeast-like symbionts (YLS) 0.5 µg/mL 36 hours Evaluate the direct antifungal activity of Sakuranetin on BPH yeast-like symbionts (YLS), results showed Sakuranetin significantly inhibited the growth of YLS Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2305007120
RAW 264.7 cells 5, 20, 50 μg/mL 48 hours To evaluate the effects of Sakuranetin on cell viability and NO release. Sakuranetin did not affect cell viability at doses from 5 to 50 μg/mL but reduced LPS-induced NO release. Mediators Inflamm. 2019 Sep 3;2019:1356356
Human liver microsomes 100 µM 60 minutes To study the metabolic stability and pathways of SKN, it was found that SKN is metabolically stable in human liver microsomes with more than 50% remaining. Molecules. 2018 Jun 26;23(7):1542
Rice root epidermal cells 100 µM 90 minutes To investigate the effect of sakuranetin on endocytosis in rice root epidermal cells, results showed that sakuranetin treatment significantly increased plasma membrane fluorescence intensity. Nat Commun. 2024 Apr 23;15(1):3437

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nilaparvata lugens (BPH) Brown planthopper (BPH) Artificial diet 0.5 µg/mL 36 hours Evaluate the effect of Sakuranetin on the endosymbionts in BPH, results showed Sakuranetin significantly reduced the number of YLS and Candida carpophila, thereby decreasing the reproductive performance and nutrition of BPH Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2305007120
Spontaneously hypertensive rats (SHR) Spontaneously hypertensive rat model Intraperitoneal injection 10, 20, 50 mg/kg Single administration, BP measured at 1, 2, 4, 8 hours post-administration To investigate the acute hypotensive effect of Sakuranetin in SHRs, results showed significant reductions in SBP and DBP at doses of 20 mg/kg and 50 mg/kg. Biomedicines. 2024 Feb 1;12(2):346
Rice Rice near-isogenic lines (NILs) Root treatment 100 μM Single treatment, 90 minutes To investigate the effect of sakuranetin on rice blast resistance, results showed that sakuranetin treatment enhanced rice resistance to rice blast. Nat Commun. 2024 Apr 23;15(1):3437
BALB/c mice Experimental asthma model Intranasal 20 mg/kg Daily from day 22 to day 29 Sakuranetin treatment attenuated airway hyperresponsiveness, inflammation and remodelling; and these effects could be attributed to Th2 pro-inflammatory cytokines and oxidative stress reduction as well as control of NF-kB activation. Br J Pharmacol. 2013 Apr;168(7):1736-49
C57BL/6J mice APAP-induced liver injury model Intraperitoneal injection 20 mg/kg Once daily for 7 days Sakuranetin significantly reduced serum ALT and AST levels, decreased liver necrosis area, reduced inflammatory factors IL-1β, IL-6, and TNF-α levels, increased GSH activity, decreased MDA levels, inhibited ROS production, increased GPX4 and SLC7A11 expression, and decreased ACSL4 expression. Drug Des Devel Ther. 2025 Jan 10;19:159-171
C57BL6 male mice Elastase-induced emphysema model Intranasal instillation 20 mg/kg Day 0 (2 h after elastase instillation), day 7, day 14, and day 28 Sakuranetin treatment reduced the alveolar enlargement, collagen and elastic fiber deposition and the number of MMP-9- and MMP-12-positive cells but increased TIMP-1 expression. In addition, sakuranetin treatment decreased the inflammation and the levels of TNF-α, IL-1β and M-CSF in the BALF as well as the levels of NF-κB and 8-iso-PGF-2α in the lungs of the elastase-treated animals. However, this treatment did not affect the changes in lung function. Respir Res. 2015 Jun 30;16(1):79
BALB/c mice Ovalbumin-induced allergic asthma model Intranasal administration 20 mg/kg Once daily from day 22 to day 29 To evaluate the anti-inflammatory effects of Sakuranetin in an allergic asthma model. Sakuranetin reduced serum IgE levels, lung inflammation (eosinophils, neutrophils, and Th2/Th17 cytokines), and respiratory epithelial mucus production. Mediators Inflamm. 2019 Sep 3;2019:1356356

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.49mL

0.70mL

0.35mL

17.47mL

3.49mL

1.75mL

34.93mL

6.99mL

3.49mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories